|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011.
|
|
2
|
Chen J, Liu X, Zhang J and Zhao Y:
Targeting HMGB1 inhibits ovarian cancer growth and metastasis by
lentivirus-mediated RNA interference. J Cell Physiol.
227:3629–3638. 2012.
|
|
3
|
Stein U, Walther W, Arlt F, et al: MACC1,
a newly identified key regulator of HGF-MET signaling, predicts
colon cancer metastasis. Nat Med. 15:59–67. 2009.
|
|
4
|
Shirahata A, Shinmura K, Kitamura Y, et
al: MACC1 as a marker for advanced colorectal carcinoma. Anticancer
Res. 30:2689–2692. 2010.
|
|
5
|
Qiu J, Huang P, Liu Q, et al:
Identification of MACC1 as a novel prognostic marker in
hepatocellular carcinoma. J Transl Med. 9:1662011.
|
|
6
|
Chundong G, Uramoto H, Onitsuka T, et al:
Molecular diagnosis of MACC1 status in lung adenocarcinoma by
immunohistochemical analysis. Anticancer Res. 31:1141–1145.
2011.
|
|
7
|
Tachibana K, Minami Y, Shiba-Ishii A, et
al: Abnormality of the hepatocyte growth factor/MET pathway in
pulmonary adenocarcinogenesis. Lung Cancer. 75:181–188. 2012.
|
|
8
|
You WK and McDonald DM: The hepatocyte
growth factor/c-Met signaling pathway as a therapeutic target to
inhibit angiogenesis. BMB Rep. 41:833–839. 2008.
|
|
9
|
Stein U, Dahlmann M and Walther W:
MACC1-more than metastasis? Facts and predictions about a novel
gene. J Mol Med. 88:11–18. 2010.
|
|
10
|
Qin X, Yan L, Zhao X, Li C and Fu Y:
microRNA-21 overexpression contributes to cell proliferation by
targeting PTEN in endometrioid endometrial cancer. Oncol Lett.
4:1290–1296. 2012.
|
|
11
|
Ye Q, Yan Z, Liao X, et al: MUC1 induces
metastasis in esophageal squamous cell carcinoma by upregulating
matrix metalloproteinase 13. Lab Invest. 91:778–787. 2011.
|
|
12
|
Wu ZS, Wang CQ, Xiang R, et al: Loss of
miR-133a expression associated with poor survival of breast cancer
and restoration of miR-133a expression inhibited breast cancer cell
growth and invasion. BMC Cancer. 12:512012.
|
|
13
|
Shimokawa H, Uramoto H, Onitsuka T, et al:
Overexpression of MACC1 mRNA in lung adenocarcinoma is associated
with postoperative recurrence. J Thorac Cardiovasc Surg.
141:895–898. 2011.
|
|
14
|
Shirahata A, Fan W, Sakuraba K, et al:
MACC 1 as a marker for vascular invasive hepatocellular carcinoma.
Anticancer Res. 31:777–780. 2011.
|
|
15
|
Shirahata A, Sakata M, Kitamura Y, et al:
MACC 1 as a marker for peritoneal-disseminated gastric carcinoma.
Anticancer Res. 30:3441–3444. 2010.
|
|
16
|
Zhang RT, Shi HR, Huang HL, et al:
Expressions of MACC1, HGF, and C-met protein in epithelial ovarian
cancer and their significance. Nan Fang Yi Ke Da Xue Xue Bao.
31:1551–1555. 2011.(In Chinese).
|
|
17
|
Zhang R, Shi H, Chen Z, et al: Effects of
metastasis-associated in colon cancer 1 inhibition by small hairpin
RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res.
30:83–107. 2011.
|
|
18
|
Chen XQ, Yang S, Kang MQ, et al: Survivin
expression in human lung cancer and the influence of its
downregulation on the biological behavior of human lung cancer
cells. Exp Ther Med. 3:1010–1014. 2012.
|
|
19
|
Liu Y: The human hepatocyte growth factor
receptor gene: complete structural organization and promoter
characterization. Gene. 215:159–169. 1998.
|
|
20
|
Mitra AK, Sawada K, Tiwari P, et al:
Ligand-independent activation of c-Met by fibronectin and
α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.
Oncogene. 30:1566–1576. 2011.
|
|
21
|
Bu R, Uddin S, Bavi P, et al: HGF/c-Met
pathway has a prominent role in mediating antiapoptotic signals
through AKT in epithelial ovarian carcinoma. Lab Invest.
91:124–137. 2011.
|
|
22
|
Seiden-Long IM, Brown KR, Shih W, et al:
Transcriptional targets of hepatocyte growth factor signaling and
Ki-ras oncogene activation in colorectal cancer. Oncogene.
25:91–102. 2006.
|
|
23
|
You H, Ding W, Dang H, Jiang Y and
Rountree CB: c-Met represents a potential therapeutic target for
personalized treatment in hepatocellular carcinoma. Hepatology.
54:879–889. 2011.
|
